1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow Kidney Dysfunction: new trials by email Literature Review of Kidney Dysfunction trials Research Report on Kidney Dysfunction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis Empagliflozin 25 MG - Peritoneal Dialysis Complication, End Stage Kidney Disease | Phase 3 | Recruiting | University Health Network, Toronto | 20 | 2024-09-01 | 2026-05-01 |
Chronic Disease (1) · Disease Attributes (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Renal Insufficiency (1) · Renal Insufficiency, Chronic (1) · Urogenital Diseases (1) · Urologic Diseases (1)
empagliflozin (1)
University Health Network, Toronto (1)
Canada (1)